[Federal Register Volume 66, Number 78 (Monday, April 23, 2001)]
[Notices]
[Pages 20472-20473]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-9919]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


White House Commission on Complementary and Alternative Medicine 
Policy; Notice of Meeting

    Pursuant to Section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is given of a meeting of the 
White House Commission on Complementary and Alternative Medicine 
Policy.
    The purpose of the meeting is to convene the Commission for a 
public hearing to receive public testimony from individuals and 
organizations interested in the subject of Federal policy regarding 
complementary and alternative medicine. The major focus of the meeting 
is coverage and reimbursement by the private and public sectors for 
Complementary and Alternative (CAM) practices and products and the 
coordination of research on Complementary and Alternative Medicine 
practices and products. Comments received at the meeting may be used by 
the Commission to prepare the Report to the President as required by 
the Executive Order.
    Invited speaker discussions focusing on the coverage and 
reimbursement for CAM practices and products on May 14-15 will include 
the following: Trends in the United States health care system including 
the underinsured and uninsured; Federal, state, and private sector 
providers' perspectives on the financing of health care and providing 
coverage and reimbursement for CAM practices and products; Employer 
coverage and reimbursement programs; and Health plans and CAM benefits. 
Invited speaker discussions focusing on the coordination of CAM 
research on May 15-16 will include the following: Not-for-profit 
support for CAM research; Approaches to evaluating research literature; 
Challenges of CAM research and research training--research methodology 
and the training of conventional and CAM research investigators; and 
Publication of peer-reviewed CAM research results.
    Some Commission members may participate by telephone conference. 
Opportunities for oral statements by the public will be provided on May 
16, from about 4:00 p.m.-5:00 p.m. (Time approximate).

    Name of Committee: The White House Commission on Complementary 
and Alternative Medicine Policy.
    Date: May 14-16, 2001.
    Time: May 14--8:15 a.m.-6:00 p.m., May 15--8:15 a.m.-6:00 p.m., 
May 16--8:15 a.m.-5:00 p.m.
    Place: Academy for Educational Development Conference Center, 
1825 Connecticut Avenue, NW., Room 800, Washington, DC 20009-5721.
    Contact Persons: Michele M. Chang, CMT, MPH, Executive 
Secretary, or, Stephen C. Groft, Pharm.D., Executive Director, 6701 
Rockledge Drive, Room 1010, MSC 7707, Bethesda, MD 20817-7707, 
Phone: (301) 435-7592, Fax: (301) 480-1691, E-mail: 
[email protected].

    Because of the need to obtain the views of the public on these 
issues as soon as possible and because of the early deadline for the 
report required of the Commission, this notice is being provided at the 
earliest possible time.

[[Page 20473]]


SUPPLEMENTARY INFORMATION: The President established the White House 
Commission on Complementary and Alternative Medicine Policy on March 7, 
2000 by Executive Order 13147. The mission of the White House 
Commission on Complementary and Alternative Medicine Policy is to 
provide a report, through the Secretary of the Department of Health and 
Human Services, on legislative and administrative recommendations for 
assuring that public policy maximizes the benefits of complementary and 
alternative medicine to Americans.

Public Participation

    The meeting is open to the public with attendance limited by the 
availability of space on a first come, first serve basis. Members of 
the public who wish to present oral comment may register by faxing a 
request to register at 301-480-1691 or by accessing the website of the 
Commission at http://whccamp.hhs.gov no later than May 4, 2001.
    Oral comments will be limited to five minutes, three minutes to 
make a statement and two minutes to respond to questions from 
Commission members. Due to time constraints, only one representative 
from each organization will be allotted time for oral testimony. The 
number of speakers and the time allotted may also be limited by the 
number of registrants. Priority may be given to participants who have 
not yet addressed the Commission at previous meetings. All requests to 
register should include the name, address, telephone number, and 
business or professional affiliation of the interested party, and 
should indicate the area of interest or question (as described above) 
to be addressed.
    Any person attending the meeting who has not registered to speak in 
advance of the meeting will be allowed to make a brief oral statement 
during the time set aside for public comment if time permits, and at 
the Chairperson's discretion. Individuals unable to attend the meeting, 
or any interested parties, may send written comments by mail, fax, or 
electronically to the staff office of the Commission for inclusion in 
the public record.
    When mailing or faxing written comments, please provide, if 
possible, an electronic version or on a diskette. Persons needing 
special assistance, such as sign language interpretation or other 
special accommodations, should contact the Commission staff at the 
address or telephone number listed above no later than May 4, 2001.

    Dated: April 16, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-9919 Filed 4-20-01; 8:45 am]
BILLING CODE 4140-01-M